Beyond coagulation: fibrinogen as a cause of cardiovascular surgical disease.
Fibrinogen is generally considered to be an important mediator of clot formation. However, its effects on clots and perhaps other more direct effects may also make it a powerful mediator in the genesis and progression of atheromatous disease. Indeed, raised fibrinogen levels may pose as great a cardiovascular risk as classical risk factors such as elevated blood pressure or cholesterol levels. The plasma fibrinogen level of any given individual, and its associated cardiovascular risk, is dependent upon an interaction between environmental and intrinsic (genetic) factors. Most environmental factors associated with elevated fibrinogen levels are also potent cardiovascular risk factors (e.g., cigarette smoking). Less is known of the role played by genetic factors. However, as research into the genotypic influences on both basal and "stimulated" fibrinogen production continues, high-risk groups may be identified that may benefit from therapeutic intervention aimed at lowering plasma fibrinogen.
Sumeray
M S
MS
Hatter Institute for Cardiovascular Studies, University College London School of Medicine, UK.
Montgomery
H E
HE
Humphries
S E
SE
D001778:Blood Coagulation Disorders / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D002318:Cardiovascular Diseases / Q000209:etiology / Q000503:physiopathology* / Q000601:surgery; D005340:Fibrinogen / Q000235:genetics / Q000502:physiology*; D005838:Genotype; D006801:Humans; D012307:Risk Factors
D005340:Fibrinogen